ArticleCureus2026
Analgesic Effects of Low Dose Ketamine in Patients Undergoing Spine Fusion Surgery.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative analgesia in spine surgeries is necessary for postoperative recovery and wound healing. While opioids have their limitations, non-opioid analgesia is a growing field of interest. Ketamine, due to its analgesic properties, has emerged as a promising agent for postoperative analgesia. Our aim was to study the analgesic effect of low-dose ketamine infusion and to explore its potential for a multimodal pain management strategy.
methodsThis prospective observational cohort study was conducted at Sher-i-Kashmir Institute of Medical Sciences, a tertiary care hospital in Srinagar, India. A total of 44 patients were observed and divided into two cohort groups of 22 each based on their intraoperative analgesic regimen. One group had received a low-dose ketamine infusion (0.3 mg/kg/hour) both intraoperatively and postoperatively, and another group received regular analgesics (fentanyl, morphine, and paracetamol) except for the ketamine infusion. Pain score measured using the Visual Analog Scale (VAS), rescue analgesic requirement, and associated side effects were studied for a period of 48 hours.
resultsKetamine administration led to a significantly lower VAS pain score at 4, 6, 12, and 18 hours postoperatively (p-value < 0.05). Adjustment for pair comparisons confirmed that the most substantial pain reduction occurred at four and six hours, indicating ketamine's early-onset analgesic effect. Patients belonging to the ketamine group also demonstrated lower cumulative opioid use (mean difference: -16.00; CI: -19.68 to -12.32, P < 0.0001) at 48 hours postoperatively, higher satisfaction with pain management, and shorter hospital stays (mean: 4.45 days vs. 5.77 days), reinforcing ketamine's potential for improving early recovery outcomes.
conclusionKetamine may demonstrate substantial promise as a safe and effective option for perioperative pain management, particularly in the early postoperative phase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.